193 related articles for article (PubMed ID: 31694075)
1. Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines.
Johansen Taber K; Lim-Harashima J; Naemi H; Goldberg J
Mol Genet Genomic Med; 2019 Dec; 7(12):e1024. PubMed ID: 31694075
[TBL] [Abstract][Full Text] [Related]
2. FMR1 premutation frequency in a large, ethnically diverse population referred for carrier testing.
Owens KM; Dohany L; Holland C; DaRe J; Mann T; Settler C; Longman RE
Am J Med Genet A; 2018 Jun; 176(6):1304-1308. PubMed ID: 29603880
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review.
Essop FB; Krause A
S Afr Med J; 2013 Oct; 103(12 Suppl 1):994-8. PubMed ID: 24300646
[TBL] [Abstract][Full Text] [Related]
4. Implementation of fragile X syndrome carrier screening during prenatal diagnosis: A pilot study at a single center.
Xi H; Xie W; Chen J; Tang W; Deng X; Li H; Peng Y; Wang D; Yang S; Zhang Y; Duan R; Fang J; Wang H
Mol Genet Genomic Med; 2021 Jul; 9(7):e1711. PubMed ID: 34057320
[TBL] [Abstract][Full Text] [Related]
5. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
[TBL] [Abstract][Full Text] [Related]
6. Preimplantation genetic diagnosis versus prenatal diagnosis-decision-making among pregnant FMR1 premutation carriers.
Haham LM; Avrahami I; Domniz N; Ries-Levavi L; Berkenstadt M; Orvieto R; Cohen Y; Elizur SE
J Assist Reprod Genet; 2018 Nov; 35(11):2071-2075. PubMed ID: 30136016
[TBL] [Abstract][Full Text] [Related]
7. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
8. Fragile X syndrome carrier screening in pregnant women in Chinese Han population.
Hung CC; Lee CN; Wang YC; Chen CL; Lin TK; Su YN; Lin MW; Kang J; Tai YY; Hsu WW; Lin SY
Sci Rep; 2019 Oct; 9(1):15456. PubMed ID: 31664061
[TBL] [Abstract][Full Text] [Related]
9. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
[TBL] [Abstract][Full Text] [Related]
10. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
Obstet Gynecol; 2010 Oct; 116(4):1008-1010. PubMed ID: 20859177
[TBL] [Abstract][Full Text] [Related]
11. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.
Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1023-1031. PubMed ID: 27333191
[TBL] [Abstract][Full Text] [Related]
12. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
[TBL] [Abstract][Full Text] [Related]
13. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
[TBL] [Abstract][Full Text] [Related]
14. Fragile X Premutation Carrier Epidemiology and Symptomatology in Israel-Results from a Tertiary Child Developmental Center.
Gabis LV; Gruber N; Berkenstadt M; Shefer S; Attia OL; Mula D; Cohen Y; Elizur SE
Cerebellum; 2016 Oct; 15(5):595-8. PubMed ID: 27312842
[TBL] [Abstract][Full Text] [Related]
15. Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.
Finucane B; Lincoln S; Bailey L; Martin CL
Prenat Diagn; 2017 Jan; 37(1):37-42. PubMed ID: 27862088
[TBL] [Abstract][Full Text] [Related]
16. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
Santa María L; Aliaga S; Faundes V; Morales P; Pugin Á; Curotto B; Soto P; Peña MI; Salas I; Alliende MA
Genet Res (Camb); 2016 Jun; 98():e11. PubMed ID: 27350105
[TBL] [Abstract][Full Text] [Related]
17. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
[TBL] [Abstract][Full Text] [Related]
18. Fragile X Syndrome: Introduction.
Reches A
Methods Mol Biol; 2019; 1942():3-10. PubMed ID: 30900171
[TBL] [Abstract][Full Text] [Related]
19. Newborn, carrier, and early childhood screening recommendations for fragile X.
Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
[TBL] [Abstract][Full Text] [Related]
20. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
